Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EIF4G1 Antikörper (pSer1232)

EIF4G1 Reaktivität: Human IHC, WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN362450
  • Target Alle EIF4G1 Antikörper anzeigen
    EIF4G1 (Eukaryotic Translation Initiation Factor 4 Gamma, 1 (EIF4G1))
    Bindungsspezifität
    • 7
    • 7
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer1232
    Reaktivität
    • 69
    • 33
    • 31
    • 6
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 1
    Human
    Wirt
    • 60
    • 7
    • 2
    Kaninchen
    Klonalität
    • 63
    • 6
    Polyklonal
    Konjugat
    • 43
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Dieser EIF4G1 Antikörper ist unkonjugiert
    Applikation
    • 33
    • 28
    • 23
    • 19
    • 8
    • 6
    • 1
    • 1
    Immunohistochemistry (IHC), Western Blotting (WB)
    Spezifität
    The antibody detects endogenous level of eIF4G only when phosphorylated at serine 1232.
    Aufreinigung
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatography using non-phosphopeptide corresponding to the phosphorylation site.
    Immunogen
    Peptide sequence around phosphorylation site of pSer1232 (P-V-S (p) -P-L) derived from Human eIF4G. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
    Isotyp
    IgG
    Top Product
    Discover our top product EIF4G1 Primärantikörper
  • Applikationshinweise
    Western blotting: 1:500-1:1000
    Immunohistochemistry: 1:50-1:100
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
  • Target
    EIF4G1 (Eukaryotic Translation Initiation Factor 4 Gamma, 1 (EIF4G1))
    Andere Bezeichnung
    eIF4G (EIF4G1 Produkte)
    Synonyme
    EIF4GI antikoerper, CG10811 antikoerper, Dmel\\CG10811 antikoerper, EIF4G antikoerper, Eif4G antikoerper, deIF4G antikoerper, eIF-4G antikoerper, eIF4g antikoerper, p200 antikoerper, EIF4G1 antikoerper, wu:fb50a05 antikoerper, wu:fc60b06 antikoerper, eif4g antikoerper, CUCUMOVIRUS MULTIPLICATION 2 antikoerper, CUM2 antikoerper, EUKARYOTIC TRANSLATION INITIATION FACTOR 4G antikoerper, eukaryotic translation initiation factor 4G antikoerper, DDBDRAFT_0217646 antikoerper, DDBDRAFT_0217647 antikoerper, DDBDRAFT_0234257 antikoerper, DDB_0217646 antikoerper, DDB_0217647 antikoerper, DDB_0234257 antikoerper, NV18824 antikoerper, EIF-4G1 antikoerper, EIF4F antikoerper, P220 antikoerper, PARK18 antikoerper, p220 antikoerper, E030015G23Rik antikoerper, eIF4GI antikoerper, eukaryotic translation initiation factor 4 gamma 1 antikoerper, eukaryotic translation initiation factor 4G antikoerper, eukaryotic translation initiation factor 4 gamma, 1a antikoerper, eukaryotic translation initiation factor 4 gamma, 1 S homeolog antikoerper, eukaryotic initiation factor antikoerper, eukaryotic translation initiation factor 4 gamma antikoerper, eukaryotic translation initiation factor 4 gamma, 1 antikoerper, eukaryotic translation initiation factor 4, gamma 1 antikoerper, EIF4G1 antikoerper, eIF4G antikoerper, eif4g1a antikoerper, LOC704923 antikoerper, eif4g1.S antikoerper, EIF4G antikoerper, eIF4g antikoerper, Eif4g antikoerper, Eif4g1 antikoerper
    Hintergrund
    EIF4F is a multi-subunit complex, the composition of which varies with external and internal environmental conditions. It is composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3. Interacts with eIF3, mutually exclusive with EIF4A1 or EIFA2, EIF4E and through its N-terminus with PAPBC1. Interacts through its C-terminus with the serine/threonine kinases MKNK1, and with MKNK2. Appears to act as a scaffold protein, holding these enzymes in place to phosphorylate EIF4E. Non-phosphorylated EIF4EBP1 competes with EIF4G1/EIF4G3 to interact with EIF4E, insulin stimulated MAP-kinase (MAPK1 and MAPK3) phosphorylation of EIF4EBP1 causes dissociation of the complex allowing EIF4G1/EIF4G3 to bind and consequent initiation of translation. EIF4G1/EIF4G3 interacts with PABPC1 to bring about circularization of the mRNA. Rapamycin can attenuate insulin stimulation mediated by FKBPs. Interacts with EIF4E3. Interacts with MIF4GD. Interacts with rotavirus A NSP3, in this interaction, NSP3 takes the place of PABPC1 thereby inducing shutoff of host protein synthesis
    Molekulargewicht
    220 kDa
    NCBI Accession
    NP_004944
    UniProt
    Q04637
Sie sind hier:
Kundenservice